ELEric Latorre-Crespo

Eric Latorre-Crespo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eric Latorre-Crespo has a total of 74 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias

    by Talha Badar, Ludovica Marando, Eric Latorre, Terra Lasho, Francyess Denis Olivia, Chenyu Lin, Benjamin J. McCormick, Mobachir El Kettani, Kashish J. Shah, Yael Kusne, et al.

    TP53 and PPM1D are key regulators of DNA damage response and repair, and somatic mutations in these genes often co-occur in hematopoietic cells, expanding under genotoxic stress. Unlike TP53 mutations, where mechanisms of progression are defined, pathways underlying clonal fitness and transformation in PPM1D mutant cells remain unclear. In collaboration with 5 academic institutions, we analyzed the clinical and molecular landscape of 337 patients with clonal hematopoiesis (CH) and clonal cytopenia of undetermined significance (CCUS) across 4 genotypes: PPM1Dmt/TP53wt (n = 170 [50%]), PPM1Dmt/TP53mt (n = 25 [7%]), TP53mt/PPM1Dwt (n = 17 [5%]), and TP53wt/PPM1Dwt (n = 125 [38%]). All PPM1D variants were truncating, located in exon 6 of the gene, with a median variant allele frequency (VAF) of 6% (range, 0.3%-64%). The PPM1Dmt/TP53mt genotype was most frequently encountered in therapy-related CH/CCUS (t-CH/t-CCUS; 80%, 66.5%, 76.5%, and 19%; P ≤ .001) and had a shorter time interval to detection from last genotoxic exposure (6.2, 5.9, 11.25, and 24.5 months; P ≤ .001) compared with PPM1Dmt/TP53wt, TP53mt/PPM1Dwt, and TP53wt/PPM1Dwt genotypes, respectively. Acknowledging the short follow-up duration, rates of malignant transformation were lower in the PPM1Dmt/TP53wt (2%) and PPM1Dmt/TP53mt (4%) groups compared with PPM1Dwt/TP53wt (12%) and PPM1Dwt/TP53mt (17%) groups (P ≤ .001), respectively. In summary, PPM1D mutations are frequently observed in t-CH/t-CCUS, with low median VAFs, and are associated with low rates of progression, even when comutated with TP53.


  • Open Access

    Clinical progression of clonal hematopoiesis is determined by a combination of mutation timing, fitness, and clonal structure

    by Eric Latorre-Crespo, Neil A. Robertson, E. Gozde Kosebent, Louise MacGillivray, Lee Murphy, Mesbah Uddin, Eric Whitsel, Michael Honigberg, Alex Bick, Alexander P. Reiner, et al.

    Clonal hematopoiesis (CH) is characterized by expanding blood cell clones carrying somatic mutations in healthy aged individuals and is associated with various age-related diseases and all-cause mortality. While CH mutations affect diverse genes associated with myeloid malignancies, their mechanisms of expansion and disease associations remain poorly understood. We investigate the relationship between clonal fitness and clinical outcomes by integrating data from three longitudinal aging cohorts (n=713, observations=2,341). We demonstrate pathway-specific fitness advantage and clonal composition influence clonal dynamics. Further, the timing of mutation acquisition is necessary to determine the extent of clonal expansion reached during the host individual’s lifetime. We introduce MACS120, a metric combining mutation context, timing, and variant fitness to predict future clonal growth, outperforming traditional variant allele frequency measurements in predicting clinical outcomes. Our unified analytical framework enables standardized clonal dynamics inference across cohorts, advancing our ability to predict and potentially intervene in CH-related pathologies.


  • Open Access

    Probabilistic inference of epigenetic age acceleration from cellular dynamics

    by Jan K. Dabrowski, Emma J. Yang, Samuel J. C. Crofts, Robert F. Hillary, Daniel J. Simpson, Daniel L. McCartney, Riccardo E. Marioni, Kristina Kirschner, Eric Latorre-Crespo, Tamir Chandra

    The emergence of epigenetic predictors was a pivotal moment in geroscience, propelling the measurement and concept of biological aging into a quantitative era; however, while current epigenetic clocks show strong predictive power, they are data-driven in nature and are not based on the underlying biological mechanisms driving methylation dynamics. We show that predictions of these clocks are susceptible to several confounding non-age-related phenomena that make interpretation of these estimates and associations difficult. To address these limitations, we developed a probabilistic model describing methylation transitions at the cellular level. Our approach reveals two measurable components, acceleration and bias, which directly reflect perturbations of the underlying cellular dynamics. Acceleration is the proportional increase in the speed of methylation transitions across CpG sites, whereas bias corresponds to global changes in methylation levels. Using data from 15,900 participants from the Generation Scotland study, we develop a robust inference framework and show that these are two distinct processes confounding current epigenetic predictors. Our results show improved associations of acceleration and bias with physiological traits known to impact healthy aging, such as smoking and alcohol consumption, respectively. Furthermore, a genome-wide association study of epigenetic age acceleration identified seven genomic loci.


  • Open Access

    DNA methylation rates scale with maximum lifespan across mammals

    by Samuel J. C. Crofts, Eric Latorre-Crespo, Tamir Chandra

    DNA methylation rates have previously been found to broadly correlate with maximum lifespan in mammals, yet no precise relationship has been observed. We developed a statistically robust framework to compare methylation rates at conserved age-related sites across mammals. We found that methylation rates negatively scale with maximum lifespan in both blood and skin. The emergence of explicit scaling suggests that methylation rates are, or are linked to, an evolutionary constraint on maximum lifespan acting across diverse mammalian lineages.


  • Open Access

    DNA methylation rates scale with maximum lifespan across mammals

    by Samuel. J. C. Crofts, Eric Latorre-Crespo, Tamir Chandra

    DNA methylation rates have previously been found to broadly correlate with maximum lifespan in mammals, yet no precise relationship has been observed. We developed a statistically robust framework to compare methylation rates at conserved age-related sites across mammals. We found that methylation rates negatively scale with maximum lifespan in both blood and skin. The emergence of explicit scaling suggests that methylation rates are - or are linked to - an evolutionary constraint on maximum lifespan acting across diverse mammalian lineages.


  • Open Access

    Probabilistic inference of epigenetic age acceleration from cellular dynamics

    by Jan. K. Dabrowski, Emma. J. Yang, Samuel. J. C. Crofts, Robert. F. Hillary, Daniel. J. Simpson, Daniel. L. Mccartney, Riccardo. E. Marioni, Eric Latorre-Crespo, Tamir Chandra

    The emergence of epigenetic predictors was a pivotal moment in geroscience, propelling the measurement and concept of biological ageing into a quantitative era. However, while current epigenetic clocks have shown strong predictive power, they do not reflect the underlying biological mechanisms driving methylation changes with age. Consequently, biological interpretation of their estimates is limited. Furthermore, our findings suggest that clocks trained on chronological age are confounded by non-age-related phenomena. To address these limitations, we developed a probabilistic model that describes methylation transitions at the cellular level. Our approach reveals two measurable components, acceleration and bias, that directly relate to perturbations of the underlying cellular dynamics. Acceleration is the proportional increase in the speed of methylation transitions across CpG sites, whereas bias is the degree of global change in methylation affecting all CpG sites uniformly. Using data from 7,028 participants from the Generation Scotland study, we found the age acceleration parameter to be associated with physiological traits known to impact healthy ageing. Furthermore, a genome-wide association study of age acceleration identified four genomic loci previously linked with ageing.


  • Open Access

    Longitudinal dynamics of clonal hematopoiesis identifies gene-specific fitness effects

    by Neil A. Robertson, Eric Latorre-Crespo, Maria Terradas-Terradas, Alison C. Purcell, Benjamin J Livesey, Joseph A. Marsh, Lee Murphy, Angie Fawkes, Louise MacGillivray, Mhairi Copland, et al.

    The prevalence of clonal haematopoiesis of indeterminate potential (CHIP) in healthy individuals increases rapidly from age 60 onwards and has been associated with increased risk for malignancy, heart disease and ischemic stroke. CHIP is driven by somatic mutations in stem cells that are also drivers of myeloid malignancies. Since mutations in stem cells often drive leukaemia, we hypothesised that stem cell fitness substantially contributes to transformation from CHIP to leukaemia. Stem cell fitness is defined as the proliferative advantage over cells carrying no or only neutral mutations. It is currently unknown whether mutations in different CHIP genes lead to distinct fitness advantages that could form the basis for patient stratification. We set out to quantify the fitness effects of CHIP drivers over a 12 year timespan in older age, using longitudinal error-corrected sequencing data. We developed a new method based on drift-induced fluctuation (DIF) filtering to extract fitness effects from longitudinal data, and thus quantify the growth potential of variants within each individual. Our approach discriminates naturally drifting populations of cells and faster growing clones, while taking into account individual mutational context. We show that gene-specific fitness differences can outweigh inter-individual variation and therefore could form the basis for personalised clinical management.


  • A class of multiparameter oscillatory singular integral operators: endpoint Hardy space bounds

    by Odysseas Bakas, Eric Latorre, Diana C. Rincón M., James Wright

    We establish endpoint bounds on a Hardy space H^1 for a natural class of multiparameter singular integral operators which do not decay away from the support of rectangular atoms. Hence the usual argument via a Journé-type covering lemma to deduce bounds on product H^1 is not valid. We consider the class of multiparameter oscillatory singular integral operators given by convolution with the classical multiple Hilbert transform kernel modulated by a general polynomial oscillation. Various characterisations are known which give L^2 (or more generally L^p , 1 < p < \infty ) bounds. Here we initiate an investigation of endpoint bounds on the rectangular Hardy space H^1 in two dimensions; we give a characterisation when bounds hold which are uniform over a given subspace of polynomials and somewhat surprisingly, we discover that the Hardy space and L^p theories for these operators are very different.

  • Open Access

    A Class of Multiparameter Oscillatory Singular Integral Operators: Endpoint Hardy Space Bounds

    by Odysseas Bakas, Eric Latorre, Diana Cristina Rincón Martínez, James Wright

    We establish endpoint bounds on a Hardy space $H^1$ for a natural class of multiparameter singular integral operators which do not decay away from the support of rectangular atoms. Hence the usual argument via a Journ\'e-type covering lemma to deduce bounds on product $H^1$ is not valid. We consider the class of multiparameter oscillatory singular integral operators given by convolution with the classical multiple Hilbert transform kernel modulated by a general polynomial oscillation. Various characterisations are known which give $L^2$ (or more generally $L^p, 1<p<\infty$) bounds. Here we initiate an investigation of endpoint bounds on the rectangular Hardy space $H^1$ in two dimensions; we give a characterisation when bounds hold which are uniform over a given subspace of polynomials and somewhat surprisingly, we discover that the Hardy space and $L^p$ theories for these operators are very different.